A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Nature Medicine Année : 2017

A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability

Frédéric Hollande
Julie Caramel

Résumé

Chromosomal instability (CIN), a feature of most adult neoplasms from their early stages onward, is a driver of tumorigenesis. However, several malignancy subtypes, including some triple-negative breast cancers, display a paucity of genomic aberrations, thus suggesting that tumor development may occur in the absence of CIN. Here we show that the differentiation status of normal human mammary epithelial cells dictates cell behavior after an oncogenic event and predetermines the genetic routes toward malignancy. Whereas oncogene induction in differentiated cells induces massive DNA damage, mammary stem cells are resistant, owing to a preemptive program driven by the transcription factor ZEB1 and the methionine sulfoxide reductase MSRB3. The prevention of oncogene-induced DNA damage precludes induction of the oncosuppressive p53-dependent DNA-damage response, thereby increasing stem cells' intrinsic susceptibility to malignant transformation. In accord with this model, a subclass of breast neoplasms exhibit unique pathological features, including high ZEB1 expression, a low frequency of TP53 mutations and low CIN.
Fichier non déposé

Dates et versions

hal-01788395 , version 1 (17-05-2018)

Identifiants

Citer

Anne Morel, Christophe Ginestier, Roxane Pommier, Olivier Cabaud, Emmanuelle Ruiz, et al.. A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability. Nature Medicine, 2017, 23 (5), pp.568 - 578. ⟨10.1038/nm.4323⟩. ⟨hal-01788395⟩
245 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More